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Conclusion: Co-infection has limited impact on immuno-
logic and virologic outcomes, but may be an important cause
of hepatotoxicity.
doi:10.1016/j.ijid.2010.02.510400 14
onths received 30% of children and 10 — 12 months 20% of
hildren (extrapulmonary tuberculosis or treatment failure).
Conclusion: In conclusion, occurrence of several oppor-
unistic infections decreased absolute CD4 count, immune
econstruction syndrome, younger age, severe anaemia,
ore than 5 opportunistic infections within 6 months, CDC
ategory C and immune stage 3 were signiﬁcantly associated
ith tuberculosis in HIV-infected children.
oi:10.1016/j.ijid.2010.02.508
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IDS-associated mycobacterial infections in a large urban
ospital during the HAART era (2003-2006)
. Sanche1,∗, M. Nguyen2
Keck School of Medicine, Los Angeles, CA, USA
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Background: Mycobacterial infections in HIV are well rec-
gnized. The aim of this study is to describe mycobacterial
nfections in HIV positive patients in a large urban setting
ith a large immigrant population in the HAART era by
ssessing mycobacterial species prevalence, clinical param-
ters, radiological ﬁndings, and survival rates.
Methods: All mycobacterial cultures reported positive at
os Angeles County-University of Southern California Hos-
ital from 2003 to 2006 were reviewed and their respective
linical charts analyzed. This descriptive retrospective study
as approved by our local Institutional Review Board.
Results: From 2003 to 2006, 965 mycobacterial isolates
ere obtained from 814 patients. Of these, 201 (25%) of
he patients were HIV positive and accounted for 262 (27%)
f the isolates. The average age of the patients was 42
ears and the male:female ratio was 166:35. 65% of the
atients’ country of origin was outside the United States.
he mean CD4 count was 137 cells/mm3 and approxi-
ately 25% of patients were receiving antiretrovirals at the
ime of mycobacterial diagnosis. Of the HIV positive iso-
ates, 30% were Mycobacterium tuberculosis and 70% were
on-tuberculosis mycobacterial infections [Mycobacterium
vium (39%), M. ﬂavascens (1%), M. fortuitum (11%), M.
ordonae (12%), M. kansasii (3%), M simiae (2%), M. ter-
ae (0.8%), and M. xenopi (0.4%)]. For the Mycobacterium
uberculosis and the non-tuberculous mycobacteria, the
ody sites from which the isolates were obtained included
ulmonary (64% and 80%), gastrointestinal (10% and 7%),
kin/soft tissue (18% and 4%), hematologic (1% and 8%), cen-
ral nervous sytstem (5% and 0.5%) and genitourinary (1% and
.5%) respectively. 83% of all patients had abnormal chest
adiographs. 3% of the M. tuberculosis isolates were multi-
rug resistant. The survival rate of patients was 91% at 6
onths, and 49 of the patients were lost to follow up.
Conclusion: Unlike previous studies that report M. tuber-
ulosis species as the predominate strain in AIDS-associated
nfections our survey demonstrated that Mycobacterium
vium infections are the most common. This has clinical
mplications when treating AIDS patients with a positive
cid-fast culture as the identiﬁcation of the specimen is
ade.
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prospective cohort study of immunologic and virologic
utcomes in patients with HIV/AIDS and hepatitis virus co-
nfection in Jos, Nigeria
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Background: In the era of highly active antiretroviral
herapy (HAART), hepatitis B and C virus (HBV and HCV) co-
nfection have emerged as signiﬁcant co-morbid conditions.
ocal reports indicate that co-infection is not uncommon in
igeria as in other sub-Saharan African countries. Whether
reatment outcomes of HIV mono-infected patients differ
rom those with co-infection remains largely unknown. We
ypothesised that co-infected patients will have lower CD4+
ount recovery and viral load reduction following HAART.
Methods: A cohort study in antiretroviral therapy-naïve
IV-infected adults involving 150 cases (HIV and hepati-
is co-infection) and 150 controls (HIV infection only).
atients’ care was according to the National guidelines
nd patients received ﬁrst line therapy mostly comprising
amivudine, Stavudine and Nevirapine. Additionally, abdom-
nal ultrasound and prothrombin time tests were done when
ecessary. Medication adherence was monitored using phar-
acy log system, and CD4+ cell counts and HIV viral load
VL) were compared at baseline, 3 and 6 months of therapy.
Results: There were 98(65.3%) and 96(64%) female cases
nd controls (p=0.79) respectively. The mean ages of cases
nd controls were 38±8.4 and 37±8.9 years (p=0.20) respec-
ively. Cases comprised 73(48%) HBV, 70(47%) HCV and 7(5%)
ith HBV plus HCV infection. Medication adherence was
95% in both arms. Attrition rate was 2.7%(8); seven of
hese were co-infected. Five cases (3.3%) compared to zero
ontrols developed clinical hepatitis. The proportions of
atients with CD4+ count <200 cells/!l among cases and
ontrols were 111(74%) and 109(72%), p=0.36 at baseline;
6(45.5%) and 64(42.7%), p=0.21 at 3 months; 60(42%) and
6(37.6%), p=0.40 at 6 months respectively. Signiﬁcantly,
ore controls (60.7%) had CD4+ increases ≥50cells/l at
months compared to 37(54.5%) HCV+ cases (p=0.03). No
igniﬁcant difference in CD4+ counts between controls and
ases at 6 months. The baseline median VL for cases and con-
rols were log104.95 and log104.83 (p=0.17) respectively.
he proportions of cases and controls with undetectable VL
t 3 and 6 months were 96(66.2%) and 97(65.5%); p=0.74,
nd 116(81.1%) and 97(79.3%); p=0.10 respectively.
